A Trial on Laparoscopic Appendectomy Versus Single Port Appendectomy

Transumbilical Single Port Laparoscopic Appendectomy Versus Conventional Laparoscopic Appendectomy in Adult Patients: A Prospective Randomized Control Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01348464

Enrollment

150

Registered

2011-05-05

Start date

2010-03-31

Completion date

2011-12-31

Last updated

2012-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Appendicitis

Keywords

appendectomy, appendicitis, laparoscopic surgery

Brief summary

The aim of this study is to compare patients who undergone single-port access laparoscopic appendectomy to those who underwent conventional three-port laparoscopic appendectomy (TPLA) in a prospective randomized trial

Detailed description

* primary objective 1\. complication rate * secondary objectives 1. satisfaction rate 2. pain scale difference

Interventions

PROCEDUREsingle port appendectomy, three port appendectomy

visual analog scale. questionnaire on wound satisfaction

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

5 Years to 85 Years

Healthy volunteers

Inclusion criteria

* age 5\ 85 years * any patient diagnosed with acute appendicitis on appendix sonography or abdominopelvic CT * Patient performance status(PS) with greater than 80 or more on Karnofsky PS * Give written informed consent prior to study specific screening procedures, with the understanding that the patient has the right to withdraw from the study at any time, without prejudice.

Exclusion criteria

* Pregnant or lactating * Serious uncontrolled intercurrent infections, or other serious uncontrolled concomitant disease * History of Previous cytotoxic chemotherapy, radiotherapy or immunotherapy, for the currently treated cancer * Clinically significant (i.e. active) cardiac disease e.g. symptomatic coronary artery disease, New York Heart Association (NYHA) grade II or greater congestive heart failure or serious cardiac arrhythmia requiring medication or myocardial infarction within the last 12 months.

Design outcomes

Primary

Measure	Time frame	Description
Complication rate	participants will be followed for the duration of hospital stay, an expected average of 24 weeks	observe complication caused by both procedures

Secondary

Measure	Time frame	Description
patient satisfaction	participants will be followed for the duration of hospital stay, an expected average of 24 weeks	Questionarire is given to the patients on postoperative 3days, 1month, 3 months and 6 months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026